Comparison of the in vitro and in vivo susceptibilities of Burkholderia mallei to Ceftazidime and Levofloxacin

BMC Microbiology

Volumn 9, Issue , 2009, Pages

  Judy, Barbara M ^a   Whitlock, Gregory C ^a   Torres, Alfredo G ^a,b   Estes, D Mark ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; LEVOFLOXACIN; ANTIINFECTIVE AGENT; OFLOXACIN;

AGAR DIFFUSION; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BURKHOLDERIA MALLEI; COLONY FORMING UNIT; COMPARATIVE STUDY; CONTROLLED STUDY; DEATH; DILUTION; DRUG EFFICACY; DRUG SENSITIVITY; DRUG UPTAKE; FEMALE; GLANDERS; IN VITRO STUDY; IN VIVO STUDY; LUNG; MACROPHAGE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; SPLEEN; SURVIVAL; ANIMAL; ANTIBIOTIC RESISTANCE; BAGG ALBINO MOUSE; CELL LINE; DRUG EFFECT; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY;

ANIMALIA; BACTERIA (MICROORGANISMS); BURKHOLDERIA MALLEI; MUS; NEGIBACTERIA;

ANIMALS; ANTI-BACTERIAL AGENTS; BURKHOLDERIA MALLEI; CEFTAZIDIME; CELL LINE; DRUG RESISTANCE, BACTERIAL; FEMALE; GLANDERS; MACROPHAGES; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; OFLOXACIN;

EID: 66649110523     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-9-88     Document Type: Article

References (26)

1. Glanders: off to the races with Burkholderia mallei. GC Whitlock DM Estes AG Torres, FEMS Microbiol Lett 2007 277 2 115 122 10.1111/j.1574-6968.2007. 00949.x 18031330
2. Bacterial agents used for bioterrorism. JK Horn, Surg Infect (Larchmt) 2003 4 3 281 287 10.1089/109629603322419625 14588163
3. First shots fired in biological warfare. M Wheelis, Nature 1998 395 6699 213 10.1038/26089 9751039
4. Pseudomonas species (including melioidosis and glanders). GB Mandell R J Dolin, Principles and practices of infectious disease New York: Churchill Livingstone, Mandell GBJ, Dolin R, 4 1995 2006 2007
5. Public health assessment of potential biological terrorism agents. LD Rotz AS Khan SR Lillibridge SM Ostroff JM Hughes, Emerg Infect Dis 2002 8 2 225 230 11897082
6. Other bacterial diseases as a potential consequence of bioterrorism: Q fever, brucellosis, glanders, and melioidosis. GW Voskuhl P Cornea MS Bronze RA Greenfield, J Okla State Med Assoc 2003 96 5 214 217 12833721
7. Laboratory-acquired human glanders. CDC, 49 MMWr: CDC 2000 532 535
8. In vitro susceptibilities of Burkholderia mallei in comparison to those of other pathogenic Burkholderia spp. DJ Kenny P Russell D Rogers SM Eley RW Titball, Antimicrob Agents Chemother 1999 43 11 2773 2775 10543761
9. In vitro antibiotic susceptibilities of Burkholderia mallei (causative agent of glanders) determined by broth microdilution and E-test. HS Heine MJ England DM Waag WR Byrne, Antimicrob Agents Chemother 2001 45 7 2119 2121 11408233 10.1128/AAC.45.7.2119-2121.2001
10. The antimicrobial susceptibility of Pseudomonas pseudomallei. Emergence of resistance in vitro and during treatment. DA Dance V Wuthiekanun W Chaowagul NJ White, J Antimicrob Chemother 1989 24 3 295 309 10.1093/jac/24.3.295 2681116
11. Oral fluoroquinolones for maintenance treatment of melioidosis. W Chaowagul Y Suputtamongkul MD Smith NJ White, Trans R Soc Trop Med Hyg 1997 91 5 599 601 10.1016/S0035-9203(97)90044-4 9463680
12. Construction of a reporter system to study Burkholderia mallei type III secretion and identification of the BopA effector protein function in intracellular survival. GC Whitlock DM Estes GM Young B Young AG Torres, Trans R Soc Trop Med Hyg 2008 102 Suppl 1 S127 133 10.1016/S0035-9203(08)70029-4 19121674
13. The animal pathogen-like type III secretion system is required for the intracellular survival of Burkholderia mallei within J774.2 macrophages. WJ Ribot RL Ulrich, Infect Immun 2006 74 7 4349 4353 16790809 10.1128/IAI.01939-05
14. Halving of mortality of severe melioidosis by ceftazidime. NJ White DA Dance W Chaowagul Y Wattanagoon V Wuthiekanun N Pitakwatchara, Lancet 1989 2 8665 697 701 10.1016/S0140-6736(89)90768-X 2570956
15. Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents. FM Thibault E Hernandez DR Vidal M Girardet JD Cavallo, J Antimicrob Chemother 2004 54 6 1134 1138 10.1093/jac/dkh471 15509614
16. Comparison of the susceptibilities of Burkholderia pseudomallei to meropenem and ceftazidime by conventional and intracellular methods. TJ Inglis F Rodrigues P Rigby R Norton BJ Currie, Antimicrob Agents Chemother 2004 48 8 2999 3005 15273112 10.1128/AAC.48.8.2999-3005.2004
17. Burkholderia pseudomallei: in vitro susceptibility to some new and old antimicrobials. R Karunakaran SD Puthucheary, Scand J Infect Dis 2007 39 10 858 861 10.1080/00365540701402988 17852912
18. Characterization of experimental equine glanders. J Lopez J Copps C Wilhelmsen R Moore J Kubay M St-Jacques S Halayko C Kranendonk S Toback D DeShazer, Microbes Infect 2003 5 12 1125 1131 10.1016/j.micinf.2003.07.004 14554254
19. Glanders. C Howe, The Oxford medicine New York: Oxford University Press, C H, 1949 185 201
20. Mouse model of sublethal and lethal intraperitoneal glanders (Burkholderia mallei). DL Fritz P Vogel DR Brown D Deshazer DM Waag, Vet Pathol 2000 37 6 626 636 10.1354/vp.37-6-626 11105952
21. Aerogenic vaccination with a Burkholderia mallei auxotroph protects against aerosol-initiated glanders in mice. RL Ulrich K Amemiya DM Waag CJ Roy D DeShazer, Vaccine 2005 23 16 1986 1992 10.1016/j.vaccine.2004.10.017 15734072
22. Identification and discrimination of Burkholderia pseudomallei, B. mallei, and B. thailandensis by real-time PCR targeting type III secretion system genes. FM Thibault E Valade DR Vidal, J Clin Microbiol 2004 42 12 5871 5874 15583328 10.1128/JCM.42.12.5871-5874.2004
23. Activity of five fluoroquinolones against 71 isolates of Burkholderia pseudomallei. PL Ho TK Cheung R Kinoshita CW Tse KY Yuen PY Chau, J Antimicrob Chemother 2002 49 6 1042 1044 10.1093/jac/dkf035 12039903
24. Comparison of efficacy of ciprofloxacin and doxycycline against experimental melioidosis and glanders. P Russell SM Eley J Ellis M Green DL Bell DJ Kenny RW Titball, J Antimicrob Chemother 2000 45 6 813 818 10.1093/jac/45.6.813 10837435
25. An ultrastructural study of the phagocytosis of Burkholderia pseudomallei. VS Harley DA Dance G Tovey MV McCrossan BS Drasar, Microbios 1998 94 377 35 45 9785484
26. Pre- and post-exposure prophylaxis of experimental Burkholderia pseudomallei infection with doxycycline, amoxicillin/clavulanic acid and co-trimoxazole. SP Sivalingam SH Sim LC Jasper D Wang Y Liu EE Ooi, J Antimicrob Chemother 2008 61 3 674 678 10.1093/jac/dkm527 18192684